In short, IPMN patients without GNAS mutation had a poor prognosis, consistent with a previous report on 149 IPMN cases among which GNAS mutation was associated with prolonged survival46. Here, GNAS is linked to pancreatic intraductal papillary-mucinous neoplasm.